Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Updating your budget keeps your financial plan accurate and actionable, helping you react to income changes and spending shifts with confidence.
21,523 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
Imagine a future where spacex worth more than Amazon becomes market reality. This article lays out the drivers, scena...
The crypto market braced for headlines as Circle faced talk of an open USD threat. Analysts argue the pullback in CRC...
When a top executive sells stock, investors want to know if it signals trouble or simply personal planning. This arti...
As 2025 earnings season unfolds, AvePoint faces a pivotal moment in cloud data governance and SaaS expansion. This gu...
A large institutional stake in Enviri sparks questions about the company’s trajectory. This article breaks down what ...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
NVIDIA is at the center of AI-driven growth, and the latest update from CEO Jensen Huang has investors buzzing. This ...
Microsoft stock moved higher in a day of broad market gains. This article breaks down the top drivers behind the surg...
Nvidia is signaling a bold financing move that could shift how investors view the stock. This deep dive breaks down t...
A viral online persona hid a troubling reality: a calculated scheme built on a bogus cancer crisis. Learn the red fla...